Cerniauskiene Liucija Rita, Reklaitiene Regina, Luksiene Dalia Ieva, Domarkiene Stanislava, Tamosiūnas Abdonas, Margeviciene Lilija
Institute of Cardiology, Kaunas University of Medicine, Sukileliu 17, 50161 Kaunas, Lithuania.
Medicina (Kaunas). 2005;41(5):435-41.
The aim of the present study was to estimate an association of metabolic syndrome with ischemic heart disease (IHD) in middle-aged Kaunas population.
The epidemiological examination was carried out in Kaunas from 2001 to 2002. Health survey was carried out according to the MONICA study protocol. Analysis was performed in 1336 persons aged 35-64 years (603 men and 733 women). Metabolic syndrome was defined by the presence of three or more out of five components: central obesity (waist circumference >102/88 cm (men/women)); fasting plasma glucose > or =6.1 mmol/l; triglycerides > or =1.7 mmol/l; high density lipoprotein cholesterol <1.04/1.3 mmol/l (men/women); systolic/diastolic blood pressure > or =130 and/or 85 mmHg. IHD was diagnosed by the criteria: previous myocardial infarction, angina pectoris or ischemic changes of electrocardiogram.
In the study population cohort prevalence of metabolic syndrome was 19.4% for men and 26.3% for women, prevalence of IHD--14.3% and 19.4%, respectively. Prevalence of metabolic syndrome and IHD among men and women increased with age. Comparing prevalence of metabolic syndrome among persons with IHD and without IHD, in the groups of men and women aged 35-44 years metabolic syndrome was not associated with IHD; in the group of men with IHD aged 45-64 years rate of metabolic syndrome was 1.8 times higher than among persons without IHD (odds ratio: 2.25 (95% CI 1.24-4.06)); in the group of women with IHD aged 45-64 years the rate of metabolic syndrome was marginally higher (1.3 times) than among women without IHD (odds ratio: 1.55 (95% CI 0.99-2.43)). The highest rate of metabolic syndrome was determined for men diagnosed with angina pectoris (odds ratio: 3.39 (95% CI 1.36-8.41)). In conclusion, study data showed that metabolic syndrome was associated with IHD in men aged 45-64 years.
本研究的目的是评估考纳斯中年人群中代谢综合征与缺血性心脏病(IHD)之间的关联。
2001年至2002年在考纳斯进行了流行病学调查。根据莫妮卡研究方案进行健康调查。对1336名年龄在35 - 64岁的人(603名男性和733名女性)进行了分析。代谢综合征由以下五个成分中的三个或更多来定义:中心性肥胖(腰围>102/88厘米(男性/女性));空腹血糖≥6.1毫摩尔/升;甘油三酯≥1.7毫摩尔/升;高密度脂蛋白胆固醇<1.04/1.3毫摩尔/升(男性/女性);收缩压/舒张压≥130和/或85毫米汞柱。IHD根据以下标准诊断:既往心肌梗死、心绞痛或心电图缺血性改变。
在研究人群队列中,男性代谢综合征患病率为19.4%,女性为26.3%,IHD患病率分别为14.3%和19.4%。男性和女性中代谢综合征和IHD的患病率随年龄增加。比较有IHD和无IHD人群中代谢综合征的患病率,在35 - 44岁的男性和女性组中,代谢综合征与IHD无关联;在45 - 64岁患有IHD的男性组中,代谢综合征的发生率比无IHD者高1.8倍(优势比:2.25(95%可信区间1.24 - 4.06));在45 - 64岁患有IHD的女性组中,代谢综合征的发生率略高(1.3倍)于无IHD的女性(优势比:1.55(95%可信区间0.99 - 2.43))。诊断为心绞痛的男性代谢综合征发生率最高(优势比:3.39(95%可信区间1.36 - 8.41))。总之,研究数据表明,代谢综合征与45 - 64岁男性的IHD有关。